This inventor holds 2 USPTO granted patents. Top assignees: Integratech Proteomics, LLC, The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2014-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 2 
2 out of 3,696 
Years Active: 2014-2016
Title: The Innovations of Robert Craigie
Introduction
Robert Craigie is an accomplished inventor based in Silver Spring, MD (US). He has made significant contributions to the field of viral research, particularly in the development of inhibitors for HIV integrase. With a total of 2 patents, Craigie's work has the potential to impact the treatment and prevention of HIV.
Latest Patents
Craigie's latest patents focus on inhibitors of viral integrase and methods of use. These patents describe compositions and methods for inhibiting HIV integrase activity. Additionally, they outline methods for identifying agents that inhibit HIV integrase for use in treating or preventing HIV. The patents also disclose methods for identifying agents that inhibit HIV viral mutants that are resistant to integrase inhibitors.
Career Highlights
Throughout his career, Robert Craigie has worked with notable organizations, including the United States of America, as represented by the Secretary, Department of Health and Human Services, and Integratech Proteomics, LLC. His work in these institutions has contributed to advancements in viral research and treatment methodologies.
Collaborations
Craigie has collaborated with various professionals in his field, including Tanya Sandrock. These partnerships have fostered innovation and the sharing of knowledge in the pursuit of effective treatments for viral infections.
Conclusion
Robert Craigie's contributions to the field of viral research, particularly through his patents on HIV integrase inhibitors, highlight his role as a significant inventor. His work continues to pave the way for advancements in the treatment and prevention of HIV.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile